Moreover, the groups of SAC alone also appeared to have fewer platelets neighboring the cancer cells, suggesting basal inhibition by SAC beyond Dox-facilitated interaction, possibly through the inhibition of platelet activation induced by ADP released by tumor cells. Here, ADCY10 is linked to cancer.